Apex Capital Management’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$40.7M Buy
386,429
+12,422
+3% +$1.19M 0.9% 47
2015
Q4
$33.3M Sell
374,007
-5,717
-2% -$510K 0.74% 56
2015
Q3
$34.4M Buy
379,724
+16,116
+4% +$1.61M 0.78% 59
2015
Q2
$38.7M Buy
+363,608
New +$36.5M 0.83% 53

Other funds holding CRI

Apex Capital Management's CRI Position: Q1 2016 in Review

Apex Capital Management increased its Carter's (CRI) stake by 3.3% in Q1 2016, buying an estimated $1.19M and bringing the position to 386,429 shares worth $40.7M. The position accounts for 0.9% of the portfolio, ranked #47.

Apex Capital Management first reported a position in CRI in Q2 2015 and has held it in 4 quarters since. 354 funds tracked by Wall St. Rank hold CRI as of Q1 2016.

  • Apex Capital Management held 386,429 shares of Carter's worth $40.7M as of Q1 2016.
  • Apex Capital Management bought 12,422 Carter's shares in Q1 2016, an estimated $1.19M.
  • Carter's made up 0.9% of Apex Capital Management's portfolio in Q1 2016, its #47 holding.
  • Apex Capital Management first reported a position in Carter's in Q2 2015 and has held it in 4 quarters since.
  • 354 funds tracked by Wall St. Rank held Carter's as of Q1 2016.

Based on Apex Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.